Role of Adenosine in Allergic Lung Disease

腺苷在过敏性肺病中的作用

• 批准号: 6729839
• 负责人: STEPHEN Lloyd TILLEY
• 金额: $ 18.25万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-01-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6729839
• 关键词: adenosine; asthma; cell surface receptors; cell type; chronic obstructive pulmonary disease; disease /disorder model; gene targeting; genetically modified animals; inflammation; laboratory mouse; mast cell; neural transmission; neuroimmunomodulation; ovalbumin; pathologic process; plethysmography; protein structure function; purinergic receptor; receptor expression; respiratory airway pressure; respiratory function; tissue /cell culture

DESCRIPTION (provided by applicant): Adenosine has become increasingly recognized as a contributor to the pathogenesis of asthma through its effects on airway tone and airway inflammation. Adenosine acts through four distinct cell surface receptors, however, the specific receptor(s) through which adenosine acts to contribute to asthma pathogenesis is largely unknown. The hypothesis that will be tested in this proposal is that adenosine contributes to both the airway tone and airway inflammation in asthma through identifiable cell surface receptors, and that inactivation of these receptors will influence the degree of bronchoconstriction and airway inflammation. We have chosen to test the hypothesis-utilizing mouse in which each adenosine receptor has been inactivated by gene targeting. We propose to carry out three specific aims to test our hypothesis. First, we will determine the adenosine receptors and cell types mediating the bronchoconstrictor effects of adenosine in the murine airway. Second, we will determine the adenosine receptors responsible for the pro- and anti-inflammatory effects of adenosine in allergic lung inflammation using the ovalbumin asthma model. Finally, we will determine the specific cell types contributing to adenosine-induced modulation of allergic inflammation. The full therapeutic potential of adenosine receptor blockade has not been exploited due to this complex physiology involving multiple adenosine receptors with diverse and sometimes opposing physiological effects. This proposal seeks to better define the pathophysiology of adenosine, acting through each receptor, in an animal model of asthma, so that a more rational exploitation of these receptors with selective pharmacological tools can be investigated in patients with asthma.

描述（由申请人提供）：腺苷通过其对气道张力和气道炎症的作用而被越来越多地认为是哮喘发病机制的贡献者。 腺苷通过四种不同的细胞表面受体起作用，然而，腺苷通过其起作用以促进哮喘发病机制的特异性受体在很大程度上是未知的。 在本提案中将检验的假设是，腺苷通过可识别的细胞表面受体促进哮喘中的气道张力和气道炎症，并且这些受体的失活将影响支气管收缩和气道炎症的程度。 我们选择测试假设利用小鼠，其中每个腺苷受体已被基因靶向灭活。 我们提出了三个具体目标来检验我们的假设。 首先，我们将确定腺苷受体和细胞类型介导的支气管收缩作用的腺苷在小鼠气道。 其次，我们将使用卵清蛋白哮喘模型确定腺苷在过敏性肺部炎症中的促炎和抗炎作用的腺苷受体。 最后，我们将确定有助于腺苷诱导的过敏性炎症调节的特定细胞类型。 腺苷受体阻断剂的全部治疗潜力尚未被开发，因为这种复杂的生理学涉及多种腺苷受体，具有不同的，有时是相反的生理作用。 该提案旨在更好地定义腺苷的病理生理学，通过每个受体，在哮喘的动物模型中发挥作用，从而可以在哮喘患者中研究这些受体与选择性药理学工具的更合理利用。